Precision Medicine Quarterly

Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

2021-01-27T06:55:18-05:00November 12th, 2020|

Thermo Fisher Scientific, the world leader in serving science, and the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University, have entered into a collaborative agreement in a bid to advance analytical capabilities and drive innovation across the biopharmaceutical industry in areas including personalized medicine, monoclonal antibodies and gene and cell therapies. BATL’s globally-recognized technical [...]

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform

2021-01-27T06:53:33-05:00November 12th, 2020|

Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the completion of its Series C funding round, raising US$50m/£39m. The round was co-led by Tencent and Legal & General and included other new investors Xeraya, Puhua Capital and IDO Investments. Existing [...]

LUNGevity Foundation Launches Inhale for Life: Right Track Public Service and Social Media Campaign During Lung Cancer Awareness Month

2021-01-27T06:47:19-05:00November 12th, 2020|

Kicking off Lung Cancer Awareness Month, LUNGevity, the nation’s leading lung cancer-focused nonprofit organization, launched its Inhale for Life: Right Track public service campaign. This powerful campaign features the stories of lung cancer survivors and their families and aims to answer the first question of people recently diagnosed with lung cancer: “What do I [...]

Caris Life Sciences Announces Huntsman Cancer Institute Joins its Precision Oncology Alliance

2021-01-27T06:43:29-05:00November 12th, 2020|

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Huntsman Cancer Institute (HCI) at the University of Utah has joined Caris’ Precision Oncology Alliance™ (The Alliance/POA). The Alliance is a collaborative network of leading cancer centers that work together to advance comprehensive cancer [...]

Exact Sciences to Acquire Thrive Earlier Detection, Becoming a Leader in Blood-Based, Multi-Cancer Screening

2021-01-27T06:35:21-05:00October 27th, 2020|

Exact Sciences Corp. (Nasdaq: EXAS) and Thrive Earlier Detection Corp. (“Thrive”), a healthcare company dedicated to incorporating earlier cancer detection into routine medical care, today announced they have entered into a definitive agreement under which Exact Sciences will acquire Thrive for cash and stock consideration of up to $2.15 billion. The transaction was unanimously approved [...]

Sema4 Announces Collaboration with Janssen on Optimizing Oncology Clinical Trials

2021-01-27T06:26:55-05:00October 1st, 2020|

Sema4, a patient-centered health intelligence company, today announced that it has entered into a research agreement with Janssen Research & Development, LLC (Janssen) to optimize oncology clinical trials. Together, Sema4 and Janssen will utilize genomic testing and advanced data analytics to more efficiently and accurately identify patients diagnosed with cancer who may be candidates for [...]

Ionis and Genuity Science announce agreement designed to rapidly translate genomic insights into therapeutics

2021-01-27T06:16:12-05:00October 1st, 2020|

Genuity Science, a genomics and data insights organization and Ionis Pharmaceuticals (NASDAQ: IONS), the leader in antisense therapeutics, today announced a broad, multi-year collaboration aimed at accelerating the discovery and development of innovative therapeutics across a range of up to 20 diseases. The collaboration is expected to play an important role in allowing Ionis to [...]

Cancer Genomic Screening Program LC-SCRUM-Asia Adopts Latest Thermo Fisher Scientific NGS Solutions

2021-01-27T05:23:13-05:00October 1st, 2020|

LC-SCRUM-Asia, a leading cancer genomic screening program, has selected Thermo Fisher Scientific’s Ion Torrent Genexus System* and Oncomine Precision Assay*, a pan-cancer panel, to advance precision medicine in Asia. The next-generation sequencing (NGS) solutions will be used in two prospective, observational projects to support the development of future therapeutics and diagnostics for non-small cell lung [...]

Lilly Oncology to Showcase New Data from Robust Cancer Research Pipeline at ESMO Virtual Congress 2020

2021-01-27T05:18:57-05:00September 10th, 2020|

Data from 20 studies across Eli Lilly and Company’s (NYSE: LLY) oncology product portfolio will be presented at the European Society for Medical Oncology (ESMO) Virtual Congress, September 19-21, 2020. The data include positive results from the Phase 3 monarchE study of Verzenio® (abemaciclib) in combination with standard adjuvant endocrine therapy (ET) for the treatment [...]

Go to Top